Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-10-009170

Options or other derivatives

  • President and CEO acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Van Hulst Jack · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2010-05-20 Grant or award : show line 1 in the form Common Stock Option +75,000 $0.61 2020-05-20 75,000 378,032 D
Loading xslF345X03/edgar.xml…